[1]冯阳,王飞,蒲柯.白杨素协同调控Alox12-GPX4/Bcl-2轴激活铁死亡抑制结直肠癌SW480细胞增殖、迁移、凋亡实验研究[J].陕西医学杂志,2026,(3):291-298.[doi:DOI:10.3969/j.issn.1000-7377.2026.03.001]
 FENG Yang,WANG Fei,PU Ke.CHR activates ferroptosis to inhibit proliferation,migration,and induce apoptosis in colorectal cancer SW480 cells by co-regulating Alox12-GPX4/Bcl-2 Axis[J].,2026,(3):291-298.[doi:DOI:10.3969/j.issn.1000-7377.2026.03.001]
点击复制

白杨素协同调控Alox12-GPX4/Bcl-2轴激活铁死亡抑制结直肠癌SW480细胞增殖、迁移、凋亡实验研究

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2026年3期
页码:
291-298
栏目:
基础研究
出版日期:
2026-03-05

文章信息/Info

Title:
CHR activates ferroptosis to inhibit proliferation,migration,and induce apoptosis in colorectal cancer SW480 cells by co-regulating Alox12-GPX4/Bcl-2 Axis
作者:
冯阳1王飞2蒲柯2
(1.西北大学附属医院 西安市第三医院,陕西 西安 710018;2.川北医学院附属医院,四川 南充 637000)
Author(s):
FENG Yang1WANG Fei2PU Ke2
(1.Affiliated Hospital of Northwest University,Xi’an 710018,China;2.Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,China)
关键词:
结直肠癌白杨素铁死亡花生四烯酸脂氧合酶12凋亡脂质过氧化谷胱甘肽过氧化物酶4
Keywords:
Colorectal cancerChrysinFerroptosisArachidonate lipoxygenase 12ApoptosisLipid peroxidationGlutathione peroxidase 4
分类号:
R 285.5
DOI:
DOI:10.3969/j.issn.1000-7377.2026.03.001
文献标志码:
A
摘要:
目的:探讨白杨素(CHR)调节花生四烯酸脂氧合酶12(Alox12)-谷胱甘肽过氧化物酶4(GPX4)/B细胞淋巴瘤-2(Bcl-2)轴激活铁死亡对结直肠癌(CRC)SW480细胞增殖、迁移、凋亡的影响。方法:基于网络药理学筛选CHR作用靶点,通过分子对接验证其与Alox12的结合能力。体外细胞实验中,采用CCK-8法筛选适合的药物作用浓度;将对数生长期SW480细胞分为NC组及20、60 μmol/LCHR组,采用平板划痕实验评估迁移能力,采用Western blot检测GPX4、Bcl-2蛋白表达,采用实时荧光定量PCR(RT-qPCR)分析Alox12 mRNA水平。结果:获得6个铁死亡-CHR-CRC交集靶点,结合蛋白质互作网络分析及分子对接确定Alox12为CHR治疗CRC的核心靶点。体外实验中,与NC组比较,60 μmol/L CHR组CRC细胞存活率、横向迁移能力被抑制,铁死亡相关蛋白GPX4和抗凋亡蛋白Bcl-2表达水平下调(均P<0.05),而20 μmol/LCHR组与NC组上述指标比较差异无统计学意义(均P>0.05);与NC组比较,60 μmol/L CHR组上调了Alox12 mRNA表达(P<0.05)。结论:CHR可抑制SW480细胞增殖与迁移,其机制可能与抑制GPX4/Bcl-2进而激活铁死亡-凋亡交叉调控网络和靶向调控Alox12有关。
Abstract:
Objective:To investigate the effects of chrysin (CHR) on proliferation,migration,and apoptosis of colorectal cancer (CRC) cells SW480 by regulating the arachidonate 12-lipoxygenase (Alox12)-glutathione peroxidase 4 (GPX4)/B-cell lymphoma-2 (Bcl-2) axis to activate ferroptosis.Methods:Potential targets of CHR were screened using network pharmacology,and molecular docking was employed to validate its binding affinity with Alox12.In the in vitro experiments,the CCK-8 assay was employed to determine the optimal drug concentrations.SW480 cells in the logarithmic growth phase were divided into the following groups:negative control (NC) group,and groups treated with 20,60 μmol/L of CHR.A wound healing assay was conducted to evaluate cell migration capability.The protein expression levels of GPX4 and Bcl-2 were detected by Western blot,while the mRNA level of Alox12 was analyzed using RT-qPCR.Results:Six overlapping targets related to ferroptosis,CHR,and CRC were identified.Combined with protein-protein interaction network analysis and molecular docking,Alox12 was determined as the core target of CHR in the treatment of CRC.In vitro,compared to the NC group,treatment with 60 μmol/L CHR significantly inhibited the survival and horizontal migration of CRC cells,and downregulated the expression of the ferroptosis-related protein GPX4 and the anti-apoptotic protein Bcl-2 (all P<0.05).In contrast,the 20 μmol/L CHR group showed no statistically significant differences in these indicators compared to the control group (all P>0.05).Furthermore,the 60 μmol/L CHR treatment significantly increased the mRNA expression of Alox12 compared to the NC group (P<0.05).Conclusion:CHR can inhibit the proliferation and migration of CRC cells,and the underlying mechanism may be associated with the suppression of GPX4/Bcl-2,thereby activating the ferroptosis-apoptosis crossover network and targeting the regulation of Alox12.

参考文献/References:

[1]SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]LI N,LU B,LUO C,et al.Incidence,mortality,survival,risk factor and screening of colorectal cancer:A comparison among China,Europe,and Northern America[J].Cancer Lett,2021,522:255-268.
[3]朱文婧,李柳,陆明,等.健脾类中药抗结直肠癌机制研究进展[J].中成药,2025,47(3):846-853.
[4]塔吉姑丽·吐逊,陈治宇,马琪琪,等.白头翁汤联合PD-1抑制剂对结肠癌小鼠免疫微环境的影响[J].陕西中医,2025,46(2):170-175.
[5]赵磊,周晓雪,谢枫,等.癌症和癌症免疫治疗中的铁死亡[J].癌症,2024,43(11):505-535.
[6]ZHOU Q,MENG Y,LI D,et al.Ferroptosis in cancer:From molecular mechanisms to therapeutic strategies[J].Signal Transduct Target Ther,2024,9(1):55.
[7]RU Q,LI Y,CHEN L,et al.Iron homeostasis and ferroptosis in human diseases:Mechanisms and therapeutic prospects[J].Signal Transduct Target Ther,2024,9(1):271.
[8]CHU B,KON N,CHEN D,et al.ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway[J].Nat Cell Biol,2019,21(5):579-591.
[9]CHEN D,CHU B,YANG X,et al.IPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4[J].Nat Commun,2021,12(1):3644.
[10]FORCINA G C,DIXON S J.GPX4 at the crossroads of lipid homeostasis and ferroptosis[J].Proteomics,2019,19(18):e1800311.
[11]柯东平,毛俊倩,刘琪,等.TRIM21调控人结直肠癌细胞增殖分子机制研究[J].陕西医学杂志,2019,48(6):691-695.
[12]LADABAUM U,DOMINITZ J A,KAHI C,et al.Strategies for colorectal cancer screening[J].Gastroenterology,2020,158(2):418-432.
[13]ZHAO L,ZHANG H,LI N,et al.Network pharmacology,a promising approach to reveal the pharmacology mechanism of Chinese medicine formula[J].J Ethnopharmacol,2023,309:116306.
[14]CHEN L,BAI D,DU J,et al.GL-V9 inhibits Caspase-11 activation-induced pyroptosis by suppressing ALOX12-mediated lipid peroxidation to alleviate sepsis[J].Br J Pharmacol,2025,182(16):3767-3785.
[15]XIE Y,KANG R,KLIONSKY D J,et al.GPX4 in cell death,autophagy,and disease[J].Autophagy,2023,19(10):2621-2638.
[16]ZHANG W,LIU Y,LIAO Y,et al.GPX4,ferroptosis,and diseases[J].Biomed Pharmacother,2024,174:116512.
[17]许丽梅,汪银枝,董丹宇,等.基于GSH/GPX4/ROS通路探讨独活寄生汤抑制软骨细胞铁死亡的机制研究[J].康复学报,2025,35(2):152-159.
[18]YANG W S,KIM K J,GASCHLER M M,et al.Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis[J].Proc Natl Acad Sci U S A,2016,113(34):E4966-E4975.
[19]YANG Y,WANG Y,DENG Y,et al.Fructus Lycii and Salvia miltiorrhiza Bunge extract attenuate oxidative stress-induced photoreceptor ferroptosis in retinitis pigmentosa[J].Biomed Pharmacother,2023,167:115547.
[20]YOU Y,ZHOU X,TANG Q,et al.Echinatin mitigates sevoflurane-induced neurotoxicity through regulation of ferroptosis and iron homeostasis[J].Aging (Albany NY),2024,16(5):4670-4683.
[21]赵志,林进权,王春雨,等.铁死亡、自噬及两者关联在胃癌发生中的研究进展[J].陕西医学杂志,2023,52(9):1268-1271.
[22]YAO Z,JIA F,WANG S,et al.The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson’s disease[J].Free Radic Biol Med,2024,222:386-396.
[23]HAN Z,BATUDELIGEN,CHEN H,et al.Luteolin attenuates CCl4-induced hepatic injury by inhibiting ferroptosis via SLC7A11[J].BMC Complement Med Ther,2024,24(1):193.
[24]TANG D,CHEN X,KANG R,et al.Ferroptosis:Molecular mechanisms and health implications[J].Cell Res,2021,31(2):107-125.
[25]WU P,ZHANG X,DUAN D,et al.Organelle-specific mechanisms in crosstalk between apoptosis and ferroptosis[J].Oxid Med Cell Longev,2023,2023:3400147.
[26]HUANG F,PANG J,XU L,et al.Hedyotis diffusa injection induces ferroptosis via the Bax/Bcl-2/VDAC2/3 axis in lung adenocarcinoma[J].Phytomedicine,2022,104:154319.

相似文献/References:

[1]柯东平,毛俊倩,刘 琪,等.TRIM21调控人结直肠癌细胞增殖分子机制研究*[J].陕西医学杂志,2019,(6):691.
 KE Dongping,MAO Junqian,LIU Qi,et al.Study on molecular mechanisms of TRIM21 in regulating proliferation of colorectal cancer[J].,2019,(3):691.
[2]张 慧,陈景志,陈建立△,等.DCC和MKK4基因在结直肠癌组织中的表达及临床意义*[J].陕西医学杂志,2019,(8):968.
 ZHANG Hui,CHEN Jingzhi,CHEN Jianli,et al.Expression and clinical significance of DDC and MKK4 genes in colorectal cancer tissue[J].,2019,(3):968.
[3]高怀军,余 伟.腹腔镜结直肠癌根治术治疗结直肠癌临床疗效及对患者胃肠功能的影响[J].陕西医学杂志,2019,(8):990.
 GAO Huaijun,YU Wei..Clinical study of laparoscopic radical resection in the treatment of colorectal cancer in and its influence on gastrointestinal function[J].,2019,(3):990.
[4]赵英旋,白玉勤.结直肠癌患者肿瘤出芽情况与临床病理特征、程序性死亡受体1及程序性死亡配体1表达相关性研究[J].陕西医学杂志,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
 ZHAO Yingxuan,BAI Yuqin.Correlation between tumor budding and clinicopathological characteristics,expression of PD-1 and PD-L1 in CRC[J].,2021,50(3):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
[5]马 骞,朱 军,蔡梦珊,等.基于exoRBase外泌体数据库结直肠癌竞争性内源RNA网络构建及富集分析[J].陕西医学杂志,2021,50(7):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
 MA Qian,ZHU Jun,CAI Mengshan,et al.Construction and enrichment analysis of competing endogenous RNA network for colorectal cancer based on the exoRBase database[J].,2021,50(3):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
[6]章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
 ZHANG Yuling,ZHOU Yue.Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features[J].,2022,51(3):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
[7]张利伟,胡海燕.粪便硫酸类肝素蛋白多糖2与分泌型卷曲相关蛋白2基因甲基化检测在结直肠癌筛查中的应用价值[J].陕西医学杂志,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
 ZHANG Liwei,HU Haiyan.Application value of feces detection of syndecan-2 and secreted frizzled related protein 2 gene methylation in colorectal cancer screening[J].,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
[8]曹巍巍,郭修田.结直肠癌原位移植造模技术研究进展[J].陕西医学杂志,2022,51(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
 CAO Weiwei,GUO Xiutian.Research progress of orthotopic transplantation technology for colorectal cancer[J].,2022,51(3):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
[9]张言言,韩 刚,曹 羽,等.同源盒基因10调控胰岛素样生长因子结合蛋白3与肠癌细胞5-氟尿嘧啶抵抗的关系研究[J].陕西医学杂志,2022,51(7):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
 ZHANG Yanyan,HAN Gang,CAO Yu,et al.Relationship between regulation of IGFBP3 by HOXD10 and 5-fluorouracil resistance in colorectal cancer cells[J].,2022,51(3):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
[10]张晓峰,冯 景,季飞燕,等.结直肠癌术后辅助化疗患者肠内营养不耐受影响因素及小野寺预后营养指数预测价值分析[J].陕西医学杂志,2022,51(9):1114.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.016]

备注/Memo

备注/Memo:
国家自然科学基金资助项目(82204877);西安市科协青年人才托举计划项目(959202313026)
更新日期/Last Update: 2026-03-05